23rd Annual Pharmaceutical / Chemical Patent Practice Update

23rd Annual Pharmaceutical / Chemical Patent Practice Update

Event Proceeding Documents

Ariad v Eli Lilly Amicus Brief
Charles Weiss

Eli Lilly, Ariad File Briefs for Federal Circuit Hearing on Written Description Requirement
Pharmaceutical Law & Industry Report

Hatch-Waxman Litigation and Reverse-Payment Settlements
Anastasia P. Winslow, Senior Counsel, Patents - Bristol-Myers Squibb Company

Identifying Section 112 Problems with a Claim
Charles Weiss

Insulin, Interferon, and EPO: A Decade of Written Description in Biotechnology Patents
Charles Weiss

Litigation in New Jersey Under the New Local Patent Rules
Honorable Jerome Simandle

Patent Term Adjustment: Recent Developments in PTA Practice and Strategies for Maximizing PTA
Jack Brennan, Fish & Richardson P.C.

Polymorphs in Pharmaceutical Products
Janet Andres

Recent Federal Circuit Cases Concerning Pharmaceutical and Biotech Inventions
Robert Schulman

Rehearing En Banc in Support of Respondent Amicus Brief

Reply Brief for Plantiffs - Appellees on Rehearing En Banc

U.S. Patent and Trademark Office Miscalculates Patent Term Adjustment
Fish & Richardson